Extracorporeal photopheresis for the treatment of autoimmune diseases

被引：22

作者：

Adamski, Jill ^{[1
]}

Kinard, Theresa ^{[1
]}

Ipe, Tina ^{[2
]}

Cooling, Laura ^{[3
]}

机构：

[1] Mayo Clin Arizona, Dept Lab Med & Pathol, Phoenix, AZ 85054 USA

[2] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA

[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2015年 / 52卷 / 02期

关键词：

Autoimmune; Photopheresis; ECP; REGULATORY T-CELLS; EPIDERMOLYSIS-BULLOSA ACQUISITA; PLACEBO-CONTROLLED TRIAL; EOSINOPHILIC FASCIITIS; PEMPHIGUS-VULGARIS; ATOPIC-DERMATITIS; PSORIATIC-ARTHRITIS; DENDRITIC CELLS; LICHEN-PLANUS; DOUBLE-BLIND;

D O I：

10.1016/j.transci.2015.02.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The immune system is tasked with the unique challenge of recognizing foreign pathogens and damaged cells while at the same time preserving and protecting the integrity of "self". When this process fails, severe consequences including cancer and autoimmunity are the end result. Current therapies aimed at treating autoimmune disorders result in generalized immunosuppression and place the patient at increased risk for infection and malignancy. ECP is a potential therapeutic intervention that recapitulates natural physiologic processes of tolerance induction to restore immune homeostasis. Several clinical trials suggest that ECP may be used to treat a broad spectrum of autoimmune diseases. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：171 / 182

页数：12

共 50 条

[21] ROLE OF EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, AUTOIMMUNE-DISEASE, AND ALLOGRAFT-REJECTION
ROOK, AH
WOLFE, JT
JOURNAL OF CLINICAL APHERESIS, 1994, 9 (01) : 28 - 30
[22] Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?
Strzepa, Anna
Lobo, Francis M.
Majewska-Szczepanik, Monika
Szczepanik, Marian
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 65 : 328 - 341
[23] The role of the extracorporeal photopheresis in the management of the graft-versus-host disease
Kaloyannidis, Panayotis
Mallouri, Despina
TRANSFUSION AND APHERESIS SCIENCE, 2012, 46 (02) : 211 - 219
[24] Extracorporeal photopheresis: Clinical use so far
Sanford, Kimberly W.
Balogun, Rasheed A.
JOURNAL OF CLINICAL APHERESIS, 2012, 27 (03) : 126 - 131
[25] European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation
Ahrens, Norbert
Geissler, Edward K.
Witt, Volker
Berneburg, Mark
Wolff, Daniel
Hirt, Stephan W.
Banas, Bernhard
Schlitt, Hans J.
Hutchinson, James A.
TRANSPLANTATION, 2018, 102 (08) : 1279 - 1283
[26] Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis
Sand, Michael
Bechara, Falk G.
Sand, Daniel
Radenhausen, Michael
Tomi, Nordwig S.
Altmeyer, Peter
Hoffmann, Klaus
DERMATOLOGY, 2007, 215 (02) : 134 - 138
[27] Does Offline Beat Inline Treatment: Investigation into Extracorporeal Photopheresis
Helmberg, Wolfgang
Sipurzynski, Sabine
Groselje-Strehle, Andrea
Greinix, Hildegard
Schlenke, Peter
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (03) : 198 - 204
[28] EXTRACORPOREAL PHOTOPHERESIS IN A RAT MODEL OF PULMONARY FIBROSIS
Remund, Kaspar
Rechsteiner, Thomas
Guo, Zhongning
Hofer, Markus
Boehler, Annette
EXPERIMENTAL LUNG RESEARCH, 2009, 35 (05) : 359 - 370
[29] Update on Extracorporeal Photopheresis in Heart and Lung Transplantation
Marques, Marisa B.
Schwartz, Joseph
JOURNAL OF CLINICAL APHERESIS, 2011, 26 (03) : 146 - 151
[30] Extracorporeal Photopheresis for the Treatment of Severe, Refractory Steroid Dependent Pediatric Crohn's Disease
Cheerva, Alexandra
Dillard, Robert
Bertolone, Salvatore
JOURNAL OF CLINICAL APHERESIS, 2013, 28 (05) : 381 - 386

← 1 2 3 4 5 →